These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17325347)

  • 101. Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge.
    Dean HJ; Leyh R
    Vaccine; 1999 Mar; 17(9-10):1117-24. PubMed ID: 10195622
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Novel bovine viral diarrhea virus (BVDV) virus-like particle vaccine candidates presenting the E2 protein using the SpyTag/SpyCatcher system induce a robust neutralizing antibody response in mice.
    Katsura M; Fukushima M; Kameyama KI; Kokuho T; Nakahira Y; Takeuchi K
    Arch Virol; 2023 Jan; 168(2):49. PubMed ID: 36609880
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Onset of protection from experimental infection with type 2 bovine viral diarrhea virus following vaccination with a modified-live vaccine.
    Brock KV; Widel P; Walz P; Walz HL
    Vet Ther; 2007; 8(1):88-96. PubMed ID: 17447228
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A novel MHC-II targeted BVDV subunit vaccine induces a neutralizing immunological response in guinea pigs and cattle.
    Bellido D; Baztarrica J; Rocha L; Pecora A; Acosta M; Escribano JM; Parreño V; Wigdorovitz A
    Transbound Emerg Dis; 2021 Nov; 68(6):3474-3481. PubMed ID: 33300298
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Development and evaluation of a monoclonal antibody-based blocking ELISA to detect antibodies against the E2 protein of bovine viral diarrhea virus-1.
    Liu X; Cheng Z; Zhang W; Mao L; Pan Z; Yang L; Liu M; Long Y; Bai J; Li W
    J Virol Methods; 2024 Jan; 323():114851. PubMed ID: 37956891
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay.
    Fulton RW; Saliki JT; Burge LJ; d'Offay JM; Bolin SR; Maes RK; Baker JC; Frey ML
    Clin Diagn Lab Immunol; 1997 May; 4(3):380-3. PubMed ID: 9144381
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody.
    Howard CJ; Clarke MC; Brownlie J
    Vet Microbiol; 1989 Mar; 19(3):195-203. PubMed ID: 2541531
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Evaluation of three experimental bovine viral diarrhea virus killed vaccines adjuvanted with combinations of Quil A cholesterol and dimethyldioctadecylammonium (DDA) bromide.
    Ridpath JF; Dominowski P; Mannan R; Yancey R; Jackson JA; Taylor L; Mediratta S; Eversole R; Mackenzie CD; Neill JD
    Vet Res Commun; 2010 Dec; 34(8):691-702. PubMed ID: 20872289
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Pathogenicity assessment of a bovine viral diarrhea virus type 1l (BVDV-1l) strain in experimentally infected calves.
    Yeşilbağ K; Aytoğu G; Kadiroğlu B; Ateş Ö; Toker EB; Yaşar M
    Vet Microbiol; 2024 Feb; 289():109945. PubMed ID: 38154395
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Co-administration of a plasmid encoding CD40 or CD63 enhances the immune responses to a DNA vaccine against bovine viral diarrhea virus in mice.
    Leng D; Yamada S; Chiba Y; Yoneyama S; Sakai Y; Hikono H; Murakami K
    J Vet Med Sci; 2022 Sep; 84(9):1175-1184. PubMed ID: 35793950
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Immunology of BVDV vaccines.
    Ridpath JF
    Biologicals; 2013 Jan; 41(1):14-9. PubMed ID: 22883306
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Novel Potent IFN-γ-Inducing CD8
    Sangewar N; Waghela SD; Yao J; Sang H; Bray J; Mwangi W
    J Immunol; 2021 Apr; 206(8):1709-1718. PubMed ID: 33762324
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Efficacy of H
    Li C; Yu J; Wang Y; Li X; Li Y; An M; Ni W; Liu K; Hu S
    BMC Vet Res; 2024 Feb; 20(1):43. PubMed ID: 38308297
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Antigenic differences between a field isolate and vaccine strains of bovine viral diarrhea virus.
    Reddy JR; Xue W; Rivera S; Minocha HC
    J Clin Microbiol; 1995 Aug; 33(8):2159-61. PubMed ID: 7559968
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Effect of treatment with a cationic antiviral compound on acute infection with bovine viral diarrhea virus.
    Newcomer BW; Marley MS; Galik PK; Zhang Y; Riddell KP; Boykin DW; Kumar A; Kuhnt LA; Gard JA; Givens MD
    Can J Vet Res; 2013 Jul; 77(3):170-6. PubMed ID: 24101792
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Non-structural proteins of bovine viral diarrhea virus.
    Chi S; Chen S; Jia W; He Y; Ren L; Wang X
    Virus Genes; 2022 Dec; 58(6):491-500. PubMed ID: 35614328
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.
    Donofrio G; Franceschi V; Capocefalo A; Taddei S; Sartori C; Bonomini S; Cavirani S; Cabassi CS; Flammini CF
    Clin Vaccine Immunol; 2009 Nov; 16(11):1675-86. PubMed ID: 19793901
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The construction of recombinant Lactobacillus casei expressing BVDV E2 protein and its immune response in mice.
    Bhuyan AA; Memon AM; Bhuiyan AA; Zhonghua L; Zhang B; Ye S; Mengying L; He QG
    J Biotechnol; 2018 Mar; 270():51-60. PubMed ID: 29408654
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Attenuated porcine-derived type 2 bovine viral diarrhea virus as vector stably expressing viral gene.
    Tao J; Li B; Shi Y; Chen J; Zhu G; Shen X; Liu H
    J Virol Methods; 2020 May; 279():113842. PubMed ID: 32135175
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Studies on the decline of bovine virus diarrhoea virus (BVDV) maternal antibodies and detectability of BVDV in persistently infected calves.
    Palfi V; Houe H; Philipsen J
    Acta Vet Scand; 1993; 34(1):105-7. PubMed ID: 8393612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.